Market Research Report

A quick peek into the report

1.1 Inclusion and Exclusion

2.1 Research Scope
2.2 Key Questions Answered by the Research Study

3.1   Primary Research
3.2   Secondary Research
3.3   Data Sources Categorization
3.4   Assumptions and Limitations
3.5   Criteria for Company Profiles Selection

4.1   Global Pediatric Genetic Testing Market Scenario
4.2   Genetic Testing Technologies Opted by Pediatrics
4.2.1   Technologies for Gene Testing in Children
4.2.1.1   Chromosome Analysis
4.2.1.1.1   Unmet Needs
4.2.1.2   Fluorescence in situ hybridization (FISH)
4.2.1.2.1   Unmet Needs
4.2.1.3   Chromosomal Microarray
4.2.1.3.1   Unmet Needs
4.2.1.4   PCR (DNA) Fragment Size Analysis
4.2.1.4.1   Unmet Needs
4.2.1.5   Single-Gene Analysis by Sanger Sequencing
4.2.1.5.1   Unmet Needs
4.2.1.6   Next-Generation Sequencing
4.2.1.6.1   Unmet Needs
4.2.1.7   Emerging Technologies
4.3   Impact of COVID-19 Pandemic on Genetic Testing Market

5.1   Overview
5.2   Legal Requirements and Framework in the U.S.
5.3   Legal Requirements and Framework in Europe
5.3.1   Germany
5.3.2   France
5.3.3   U.K.
5.3.4   Spain
5.4   Regulation in APAC
5.4.1   China
5.4.2   Japan
5.4.3   South-Korea
5.5   Patent Analysis

6.1   Key Developments and Strategies
6.2   New Offerings
6.3   Synergistic Activities
6.4   Product Approval
6.5   Business Expansion
6.6   Market Share Analysis
6.7   Growth-Share Analysis

7.1   Market Drivers
7.1.1   Significant Number of Pediatric Genetic Disorders causing Birth Defects and Deaths
7.1.2   Decreasing Cost of Genetic Testing Globally
7.1.3   Decrease in Overall Cost and Time of Care
7.1.4   Advancements within Molecular Techniques for Clinical Diagnostics
7.2   Market Restrains
7.2.1   Challenging Regulatory Scenario
7.2.2   Uncertainty in Reimbursement of Genetic Testing
7.3   Market Opportunities
7.3.1   Increasing Awareness for Newborn Genetic Testing and Counseling
7.3.2   Rising Funding and Innovations

8.1   Overview
8.2   Blood
8.3   Saliva
8.4   Tissue
8.5   Bone Marrow

9.1   Overview
9.2   Kits
9.3   Laboratory Developed Tests (LDT)
9.4   Reagents

10.1   Overview
10.2   Somatic Disorders
10.3   Inherited Disorders

11.1   Overview
11.2   Developmental Disorders
11.3   Neurological Disorders
11.4   Cardiovascular Disorders
11.5   Others

12.1   Overview
12.2   Sequencing
12.3   Polymerase Chain Reaction
12.4   In Situ Hybridization (ISH/FISH)
12.5   Microarray Techniques

13.1   Overview
13.2   Clinical Diagnostics
13.3   Monitoring and Screening
13.4   Drug Discovery
13.5   Academic and Research

14.1   Overview
14.2   North America
14.2.1   U.S.
14.2.2   Canada
14.3   Europe
14.3.1   Germany
14.3.2   U.K.
14.3.3   France
14.3.4   Italy
14.3.5   Spain
14.3.6   Rest-of-Europe
14.4   Asia-Pacific
14.4.1   Japan
14.4.2   China
14.4.3   India
14.4.4   Australia
14.4.5   South-Korea
14.4.6   Rest-of-Asia-Pacific
14.5   Latin America
14.5.1   Brazil
14.5.2   Mexico
14.5.3   Rest-of-Latin America
14.6   Rest-of-the-World

15.1   Abbott Laboratories
15.1.1   Company Overview
15.1.2   Role of Abbott Laboratories in the Global Pediatric Genetic Testing Market
15.1.3   Financials
15.1.4   SWOT Analysis
15.2   Agilent Technologies, Inc.
15.2.1   Company Overview
15.2.2   Role of Agilent Technologies, Inc. in the Global Pediatric Genetic Testing Market
15.2.3   Financials
15.2.4   SWOT Analysis
15.3   BGI Genomics
15.3.1   Company Overview
15.3.2   Role of BGI Genomics in the Global Pediatric Genetic Testing Market
15.3.3   SWOT Analysis
15.4   Baebies
15.4.1   Company Overview
15.4.2   Role of Baebies in the Global Pediatric Genetic Testing Market
15.4.3   SWOT Analysis
15.5   CENTOGENE AG
15.5.1   Company Overview
15.5.2   Role of Centogene AG in the Global Pediatric Genetic Testing Market
15.5.3   SWOT Analysis
15.6   Fulgent Genetics, Inc.
15.6.1   Company Overview
15.6.2   Role of Fulgent Genetics, Inc. in the Global Pediatric Genetic Testing Market
15.6.3   Financials
15.6.4   SWOT Analysis
15.7   Genomic Diagnostics
15.7.1   Company Overview
15.7.2   Role of Genomic Diagnostics in the Global Pediatric Genetic Testing Market
15.7.3   SWOT Analysis
15.8   Invitae Corporation
15.8.1   Company Overview
15.8.2   Role of Invitae Corporation in the Global Pediatric Genetic Testing Market
15.8.3   Financials
15.8.4   SWOT Analysis
15.9   LifeCell International Pvt. Ltd.
15.9.1   Company Overview
15.9.2   Role of Life Cell International Pvt. Ltd. in the Global Pediatric Genetic Testing Market
15.9.3   SWOT Analysis
15.10 OPKO Health, Inc.
15.10.1   Company Overview
15.10.2   Role of OPKO Health, Inc. in the Global Pediatric Genetic Testing Market
15.10.3   Financials
15.10.4   SWOT Analysis
15.11   PerkinElmer, Inc.
15.11.1   Company Overview
15.11.2   Role of PerkinElmer, Inc. in the Global Pediatric Genetic Testing Market
15.11.3   Financials
15.11.4   SWOT Analysis
15.12   Quest Diagnostics
15.12.1   Company Overview
15.12.2   Role of Quest Diagnostics in the Global Pediatric Genetic Testing Market
15.12.3   Financials
15.12.4   SWOT Analysis
15.13   Thermo Fisher Scientific Inc.
15.13.1   Company Overview
15.13.2   Role of Thermo Fisher Scientific Inc.in the Global Pediatric Genetic Testing Market
15.13.3   Financials
15.13.4   SWOT Analysis
15.14   Trivitron Healthcare
15.14.1   Company Overview
15.14.2   Role of Trivitron Healthcare in the Global Pediatric Genetic Testing Market
15.14.3   SWOT Analysis
15.15   Unilabs
15.15.1   Company Overview
15.15.2   Role of Unilabs in the Global Pediatric Genetic Testing Market
15.15.3   SWOT Analysis

Table 5.1: Regulatory Bodies Governing Genetic Testing

Figure 1:   Number of Deaths due to Down Syndrome, 2012-2015
Figure 2:   Global Pediatric Genetic Testing Market, 2019 and 2030
Figure 3:   Market Drivers, Market Opportunities and Market Restraints
Figure 4:   Share of Key Developments and Strategies, January 2015-May 2020
Figure 5:   Growth Share Matrix for Global Pediatric Genetic Testing Market (by Company), 2018
Figure 6:   Share of Global Pediatric Genetic Testing Market (by Technology), 2019-2030
Figure 7:   Global Pediatric Genetic Testing Market (by Region), 2019 and 2030
Figure 2.1:   Global Pediatric Genetic Testing Market Segmentation
Figure 3.1:   Global Pediatric Genetic Testing Market Research Methodology
Figure 3.2:   Primary Research
Figure 3.3:   Secondary Research
Figure 3.4:   Share of Total Number of Companies Profiled
Figure 4.1:   Global Pediatric Genetic Testing Market, 2019-2030
Figure 4.2:   Diagnostic Approach for Newborns with Multiple Congenital Anomalies
Figure 4.3:   Positive and Negative Impact of COVID-19 on Pediatric Genetic Testing Market
Figure 5.1:   Total Patents Filed, by Technology (2015-2018)
Figure 6.1:   Share of Key Developments and Strategies, January 2015-May 2020
Figure 6.2:   New Offerings and Product Approval Share (by Company), January 2015–May 2020
Figure 6.3:   Synergistic Activities Share (by Company), January 2015- May 2020
Figure 6.4:   Product Approval Share (by Company), January 2015-May 2020
Figure 6.5:   Business Expansion Activities (by Company), January 2015- May 2020
Figure 6.6:   Market Share Analysis of Pediatric Genetic Testing Market (by Company), 2019
Figure 6.7:   Growth Share Matrix for Global Pediatric Genetic Testing Market (by Company), 2018
Figure 7.1:   Impact of Market Drivers and Restraints on Global Pediatric Genetic Testing, 2019-2030
Figure 8.1:   Share of Global Pediatric Genetic Testing Market (by Sample Type), 2019-2030
Figure 8.2:   Global Pediatric Genetic Testing Market (by Blood Sample), 2019-2030
Figure 8.3:   Global Pediatric Genetic Testing Market (by Saliva Sample), 2019-2030
Figure 8.4:   Global Pediatric Genetic Testing Market (by Tissue Sample), 2019-2030
Figure 8.5:   Global Pediatric Genetic Testing Market (by Bone Marrow Sample), 2019-2030
Figure 9.1:   Share of Global Pediatric Genetic Testing Market (by Product Type), 2019-2030
Figure 9.2:   Pediatric Genetic Testing Market (by Kits), 2019-2030
Figure 9.3:   Pediatric Genetic Testing Market (by LDT), 2019-2030
Figure 9.4:   Pediatric Genetic Testing Market (by Reagents), 2019-2030
Figure 10.1:   Share of Global Pediatric Genetic Testing Market (by Origin), 2019-2030
Figure 10.2:   Pediatric Genetic Testing Market (by Somatic Disorder), 2019-2030
Figure 10.3:   Pediatric Genetic Testing Market (by Inherited Disorder), 2019-2030
Figure 11.1:   Share of Global Pediatric Genetic Testing Market (by Disorder Type), 2019-2030
Figure 11.2:   Global Pediatric Genetic Testing Market (by Developmental Disorder), 2019-2030
Figure 11.3:   Global Pediatric Genetic Testing Market (by Neurological Disorder), 2019-2030
Figure 11.4:   Global Pediatric Genetic Testing Market (by Cardiovascular Disorder), 2019 2030
Figure 11.5:   Global Pediatric Genetic Testing Market (by Others), 2019 2030
Figure 12.1:   Share of Global Pediatric Genetic Testing Market (by Technology), 2019-2030
Figure 12.2:   Global Pediatric Genetic Testing Market (by Sequencing), 2019-2030
Figure 12.3:   Global Pediatric Genetic Testing Market (by PCR), 2019-2030
Figure 12.4:   Global Pediatric Genetic Testing Market (by ISH), 2019-2030
Figure 12.5:   Global Pediatric Genetic Testing Market (by Microarray), 2019-2030
Figure 13.1:   Share of Global Pediatric Genetic Testing Market (by Application), 2019-2030
Figure 13.2:   Global Pediatric Genetic Testing Market (by Clinical Diagnostics), 2019-2030
Figure 13.3:   Global Pediatric Genetic Testing Market (by Monitoring and Screening), 2019-2030
Figure 13.4:   Global Pediatric Genetic Testing Market (by Drug Discovery), 2019-2030
Figure 13.5:   Global Pediatric Genetic Testing Market (by Academic and Research), 2019-2030
Figure 14.1:   Global Pediatric Genetic Testing Market (by Region), 2019 and 2030
Figure 14.2:   North America: Market Dynamics
Figure 14.3   : North America Pediatric Genetic Testing Market (by Country), 2019-2030
Figure 14.4:   U.S. Pediatric Genetic Testing Market, 2019-2030
Figure 14.5:   Canada Pediatric Genetic Testing Market, 2019-2030
Figure 14.6:   Europe Pediatric Genetic Testing Market, 2019-2030
Figure 14.7:   Europe: Market Dynamics
Figure 14.8:   Europe Pediatric Genetic Testing Market (by Country), 2019-2030
Figure 14.9:   Number of Live Births in Germany (2012-2018)
Figure 14.10:   Germany Pediatric Genetic Testing Market, 2019-2030
Figure 14.11:   U.K. Pediatric Genetic Testing Market, 2019-2030
Figure 14.12:   France Pediatric Genetic Testing Market, 2019-2030
Figure 14.13:   Italy Pediatric Genetic Testing Market, 2019-2030
Figure 14.14:   Spain Pediatric Genetic Testing Market, 2019-2030
Figure 14.15:   Rest-of-Europe Pediatric Genetic Testing Market, 2019-2030
Figure 14.16:   Asia-Pacific Pediatric Genetic Testing Market, 2019-2030
Figure 14.17:   Asia-Pacific: Market Dynamics
Figure 14.18:   Asia-Pacific Pediatric Genetic Testing Market (by Country), 2019-2030
Figure 14.19:   Total Live Births with Down’s Syndrome in Japan, (2012-2016)
Figure 14.20:   Japan Pediatric Genetic Testing Market, 2019-2030
Figure 14.21:   China Pediatric Genetic Testing Market, 2019-2030
Figure 14.22:   India Pediatric Genetic Testing Market, 2019-2030
Figure 14.23:   Australia Pediatric Genetic Testing Market, 2019-2030
Figure 14.24:   South-Korea Pediatric Genetic Testing Market, 2019-2030
Figure 14.25:   Rest-of-Asia-Pacific Pediatric Genetic Testing Market, 2019-2030
Figure 14.26:   Latin America Pediatric Genetic Testing Market, 2019-2030
Figure 14.27:   Latin America: Market Dynamics
Figure 14.28:   Latin America Global Pediatric Genetic Testing Market (by Country), 2019 and 2030
Figure 14.29:   Brazil Pediatric Genetic Testing Market, 2019-2030
Figure 14.30:   Mexico Pediatric Genetic Testing Market, 2019-2030
Figure 14.31:   Rest-of-Latin-America Pediatric Genetic Testing Market, 2019-2030
Figure 14.32:   Rest-of-the-World Pediatric Genetic Testing Market, 2019-2030
Figure 15.1:   Abbott Laboratories.: Overall Product Offerings
Figure 15.2:   Abbott Laboratories: Overall Financials, 2016-2018
Figure 15.3:   Abbott Laboratories: Net Revenue (by Business Segment), 2017-2019
Figure 15.4:   Abbott Laboratories: Net Revenue (by Region), 2017-2019
Figure 15.5:   Abbott Laboratories: Research and Development Expense, 2017-2019
Figure 15.6:   Abbott Laboratories: SWOT Analysis
Figure 15.7:   Agilent Technologies, Inc..: Overall Product Offerings
Figure 15.8:   Agilent Technologies, Inc.: Overall Financials, 2017-2019
Figure 15.9:   Agilent Technologies, Inc.: Net Revenue (by Business Segment), 2016-2018
Figure 15.10:   Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 15.11:   Agilent Technologies, Inc.: Research and Development Expense, 2017-2019
Figure 15.12:   Agilent Technologies, Inc.: SWOT Analysis
Figure 15.13:   BGI Genomics.: Overall Product Offerings
Figure 15.14:   BGI Genomics: SWOT Analysis
Figure 15.15:   Baebies: Overall Product Offerings
Figure 15.16:   Baebies: SWOT Analysis
Figure 15.17:   Centogene AG: Overall Product Offerings
Figure 15.18:   Centogene AG: SWOT Analysis
Figure 15.19:   Fulgent Genetics, Inc..: Overall Product Offerings
Figure 15.20:   Fulgent Genetics, Inc.: Overall Financials, 2017-2019
Figure 15.21:   Fulgent Genetics, Inc.: Net Revenue (by Region), 2017-2019
Figure 15.22:   Fulgent Genetics, Inc.: Research and Development Expense, 2017-2019
Figure 15.23:   Fulgent Genetics, Inc.: SWOT Analysis
Figure 15.24:   Genomic Diagnostics: Overall Product Offerings
Figure 15.25:   Genomic Diagnostics: SWOT Analysis
Figure 15.26:   Invitae Corporation: Overall Product Offerings
Figure 15.27:   Invitae Corporation: Overall Financials, 2017-2019
Figure 15.28:   Invitae Corporation: Revenue (by Segment), 2017-2019
Figure 15.29:   Invitae Corporation: Revenue (by Region), 2017-2019
Figure 15.30:   Invitae Corporation: R&D Expenditure, 2017-2019
Figure 15.31:   Invitae Corporation: SWOT Analysis
Figure 15.32:   LifeCell International Pvt. Ltd.: Overall Product Offerings
Figure 15.33:   LifeCell International Pvt. Ltd.: SWOT Analysis
Figure 15.34:   OPKO Health, Inc.: Overall Product Offerings
Figure 15.35:   OPKO Health, Inc.: Overall Financials, 2017-2019
Figure 15.36:   OPKO Health, Inc: Net Revenue (by Business Segment), 2016-2018
Figure 15.37:   OPKO Health, Inc.: Net Revenue (by Region), 2017-2019
Figure 15.38:   OPKO Health, Inc.: Research and Development Expense, 2017-2019
Figure 15.39:   OPKO Health, Inc.: SWOT Analysis
Figure 15.40:   PerkinElmer, Inc.: Overall Product Offerings
Figure 15.41:   PerkinElmer, Inc: Overall Financials, 2017-2019
Figure 15.42:   PerkinElmer, Inc.: Revenue (by Segment), 2017-2019
Figure 15.43:   PerkinElmer, Inc.: R&D Expenditure, 2017-2019
Figure 15.44:   PerkinElmer, Inc.: SWOT Analysis
Figure 15.45:   Quest Diagnostics Incorporated: Overall Product Offerings
Figure 15.46:   Quest Diagnostics Incorporated: Overall Financials, 2017-2019
Figure 15.47:   Quest Diagnostics Incorporated: Revenue (by Business Segment), 2017-2019
Figure 15.48:   Quest Diagnostics Incorporated: SWOT Analysis
Figure 15.49   Thermo Fisher Scientific Inc.: Overall Product Offerings
Figure 15.50:   Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
Figure 15.51:   Thermo Fisher Scientific Inc.: Revenue (by Segment), 2017-2019
Figure 15.52:   Thermo Fisher Scientific Inc.: Revenue (by Geography), 2017-2019
Figure 15.53:   Thermo Fisher Scientific Inc: R&D Expenditure, 2017-2019
Figure 15.54:   Thermo Fisher Scientific Inc: SWOT Analysis
Figure 15.55:   Trivitron Healthcare: Overall Product Offerings
Figure 15.56:   Trivitron Healthcare: SWOT Analysis
Figure 15.57:   Unilabs: Overall Product Offerings
Figure 15.58:   Unilabs: SWOT Analysis

Report Description

Market Report Coverage - Pediatric Genetic Testing
Base Year	2019	Market Size in 2019	$2.78 Billion
Forecast Period	2020-2030	Value Projection and Estimation by 2030	$12.06 Billion
CAGR During Forecast Period	14.30%	Number of Tables	1
Number of Pages	210	Number of Figures	141
Research Hours	700
Market Segmentation	• By Origin: Somatic Disorders and Inherited Disorders • By Sample Type: Tissue, Bone Marrow, Blood, Saliva • By Product Type: Kits, LDT Tests, Reagents • By Disease Type: Neurological Disorders, Cardiac Disorders, Developmental Disorders, Others • By Application Area: Academic and Research, Clinical Diagnostics, Drug Discovery, Monitoring, and Screening • By Region: North America, Europe, Asia Pacific, Latin America, and Rest-of-the-World
Regional Segmentation	• North America – Country Specific Stratification • Europe – Country Specific Stratification • Asia-Pacific – Country Specific Stratification • Latin America – Country Specific Stratification • Rest-of-the-World
Growth Drivers	• Significant Number of Pediatric Genetic Disorders causing Birth Defects and Deaths • A Decrease in Cost of Genetic Testing Globally • Advancements within Molecular Techniques for Clinical Diagnostics
Market Challenges	• Challenging Regulatory Scenario • Uncertainty in Reimbursement of Genetic Testing
Market Opportunities	• Increasing Awareness for Newborn Genetic Testing and Counseling • Uncertainty in Reimbursement of Genetic Testing
Key Companies Profiled	Eurofins Scientific, Abbott Laboratories, Invitae Corporation, Fulgent Genetics., Agilent Technologies, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Genomic Diagnostics, Unilabs, LifeCell International Pvt. Ltd., Trivitron Healthcare and Baebies, Inc.

Key Questions Answered in this Report:

•   What are the different types of products and services available in the pediatric genetic testing market, and what are the benefits offered by them?
•   What are the major drivers, challenges, and opportunities in the global pediatric genetic testing market?
•   What are the key development strategies implemented by the key players to stand out in this market?
•   What are the regulations pertaining to the global pediatric genetic testing market?
•   What are the initiatives implemented by different government bodies regulating the development and commercialization of genetic testing products and services?
•   What are the leading companies dominating the global pediatric genetic testing market?
•   What are the upcoming technologies that can take over the current technologies for pediatric genetic testing?
•   What is the reimbursement scenario of the products offered in the global pediatric genetic testing market?
•   What is the average cost of available technologies in pediatric genetic testing?
•   Based on the application, which pediatric genetic testing application is anticipated to witness a massive rise in demand in the forecast period?
•   What was the market value in 2019 of the leading segments and sub-segments of the global pediatric genetic testing market?
•   How is each segment of the global pediatric genetic testing market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2030?
•   How is the industry anticipated to evolve during the forecast period 2020-2030?
•   Which region is expected to contribute to the highest sales of the global pediatrics genetic testing market during the forecast period?
•   What are the leading trends and consumer preferences witnessed in the global pediatric genetic testing markets?

Market Overview

Genetic testing within the newborns, infants, and adolescents is performed to identify the cause of developmental delay, multiple malformations, intellectual disability, and dysmorphic features, among others. The genetic tests are also used to rule out chromosomal abnormalities and single genes via various molecular and cytogenetic genetic techniques. These tests further can help the parents understand the reason behind the disorders and also manage the disease at an early stage.

The global pediatrics genetic testing market was valued $2,782.8 million in 2019, and it is expected to grow at an impressive double-digit rate of 14.30% and reach a value of 12,063.2 million in 2030. The following figure represents the global pediatrics genetic testing market.

The existing pediatric genetic testing market is favored by multiple factors, which include rising government initiatives, coupled up with the general population’s growing awareness pertaining to genetic conditions. Additionally, the increasing number of advancements in molecular diagnostics, more genetic counselors are some of the key driving factors for the pediatric genetic testing market.

Within the research report, the market is segmented on the basis of origin (somatic disorders and hereditary disorders ), sample type (tissue, bone marrow, blood and saliva), product type (kits, LDT tests, and reagents), disease type (neurological disorder, cardiac disorder, developmental disorder, and others), application area (academic and research, clinical diagnostics, drug discovery and monitoring and screening), and region (North America, Europe, Asia Pacific, Latin America, and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.

Competitive Landscape

The pediatric genetic testing market has witnessed 16 product offerings, two product approvals, nine partnerships and alliances, two mergers and acquisitions, and four business expansions in the past five years (January 2015- May 2020).

Major players within the pediatric genetic testing market are Quest Diagnostics, Centogene AG, Opko Health, Inc., Eurofins Scientific, Abbott Laboratories, Invitae Corporation, Fulgent Genetics., Agilent Technologies, Inc., PerkinElmer, Inc., Thermofisher Scientific, Genomic Diagnostics, Unilabs, LifeCell International Pvt. Ltd., Trivitron Healthcare and Baebies, Inc.